Current drugs specifically targeting EGFR tyrosine kinase activity or selectively inhibiting mTOR, a PI3K/Akt downstream signal transducer showed little efficacy in treatment of primary glioblastoma [18]. The gene discussed is AKT1; the disease is glioblastoma.